Asim Rizvi1, Bríain Ó Hartaigh1, Ibrahim Danad1, Donghee Han1, Ji Hyun Lee1, Heidi Gransar2, Jackie Szymonifka1, Fay Y Lin3, James K Min4. 1. Dalio Institute of Cardiovascular Imaging, Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, United States. 2. Departments of Imaging and Medicine, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States. 3. Dalio Institute of Cardiovascular Imaging, Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, United States; Departments of Radiology and Medicine, Weill Cornell Medicine, New York, NY, United States. 4. Dalio Institute of Cardiovascular Imaging, Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, United States; Departments of Radiology and Medicine, Weill Cornell Medicine, New York, NY, United States. Electronic address: jkm2001@med.cornell.edu.
Abstract
BACKGROUND AND AIMS: Coronary computed tomography angiography (CCTA) permits effective identification of diffuse CAD and atherosclerotic plaque characteristics (APCs). We sought to examine the usefulness of diffuse CAD beyond luminal narrowing and APCs by CCTA to detect vessel-specific ischemia. METHODS: 407 vessels (n = 252 patients) from the DeFACTO diagnostic accuracy study were retrospectively analyzed for percent plaque diffuseness (PD). Percent plaque diffuseness (PD) was obtained on per-vessel level by summation of all contiguous lesion lengths and divided by total vessel length, and was logarithmically transformed (log percent PD). Additional CCTA measures of stenosis severity including minimal lumen diameter (MLD), and APCs, such as positive remodeling (PR) and low attenuation plaque (LAP), were also included. Vessel-specific ischemia was defined as fractional flow reserve (FFR) ≤0.80. Multivariable regression, discrimination by area under the receiver operating characteristic curve (AUC), and category-free net reclassification improvement (cNRI) were assessed. RESULTS: Backward stepwise logistic regression revealed that for every unit increase in log percent PD, there was a 58% (95% CI: 1.01-2.48, p = 0.048) rise in the odds of having an abnormal FFR, independent of stenosis severity and APCs. The AUC indicated no further improvement in discriminatory ability after adding log percent PD to the final parsimonious model of MLD, PR, and LAP (AUC difference: 0.003, 95% CI: -0.003-0.010, p = 0.33). Conversely, adding log percent PD to the base model of MLD, PR, and LAP improved cNRI by 0.21 (95% CI: 0.01-0.41, p < 0.001). CONCLUSIONS: Accounting for diffuse CAD may help improve the accuracy of CCTA for detecting vessel-specific ischemia.
BACKGROUND AND AIMS: Coronary computed tomography angiography (CCTA) permits effective identification of diffuse CAD and atherosclerotic plaque characteristics (APCs). We sought to examine the usefulness of diffuse CAD beyond luminal narrowing and APCs by CCTA to detect vessel-specific ischemia. METHODS: 407 vessels (n = 252 patients) from the DeFACTO diagnostic accuracy study were retrospectively analyzed for percent plaque diffuseness (PD). Percent plaque diffuseness (PD) was obtained on per-vessel level by summation of all contiguous lesion lengths and divided by total vessel length, and was logarithmically transformed (log percent PD). Additional CCTA measures of stenosis severity including minimal lumen diameter (MLD), and APCs, such as positive remodeling (PR) and low attenuation plaque (LAP), were also included. Vessel-specific ischemia was defined as fractional flow reserve (FFR) ≤0.80. Multivariable regression, discrimination by area under the receiver operating characteristic curve (AUC), and category-free net reclassification improvement (cNRI) were assessed. RESULTS: Backward stepwise logistic regression revealed that for every unit increase in log percent PD, there was a 58% (95% CI: 1.01-2.48, p = 0.048) rise in the odds of having an abnormal FFR, independent of stenosis severity and APCs. The AUC indicated no further improvement in discriminatory ability after adding log percent PD to the final parsimonious model of MLD, PR, and LAP (AUC difference: 0.003, 95% CI: -0.003-0.010, p = 0.33). Conversely, adding log percent PD to the base model of MLD, PR, and LAP improved cNRI by 0.21 (95% CI: 0.01-0.41, p < 0.001). CONCLUSIONS: Accounting for diffuse CAD may help improve the accuracy of CCTA for detecting vessel-specific ischemia.
Authors: P J Scanlon; D P Faxon; A M Audet; B Carabello; G J Dehmer; K A Eagle; R D Legako; D F Leon; J A Murray; S E Nissen; C J Pepine; R M Watson; J L Ritchie; R J Gibbons; M D Cheitlin; T J Gardner; A Garson; R O Russell; T J Ryan; S C Smith Journal: J Am Coll Cardiol Date: 1999-05 Impact factor: 24.094
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: K L Gould; Y Nakagawa; K Nakagawa; S Sdringola; M J Hess; M Haynie; N Parker; N Mullani; R Kirkeeide Journal: Circulation Date: 2000-04-25 Impact factor: 29.690
Authors: Michael J Blaha; Matthew J Budoff; Rajesh Tota-Maharaj; Zeina A Dardari; Nathan D Wong; Richard A Kronmal; John Eng; Wendy S Post; Roger S Blumenthal; Khurram Nasir Journal: JACC Cardiovasc Imaging Date: 2016-04-13
Authors: Hyung-Bok Park; Ran Heo; Bríain Ó Hartaigh; Iksung Cho; Heidi Gransar; Ryo Nakazato; Jonathon Leipsic; G B John Mancini; Bon-Kwon Koo; Hiromasa Otake; Matthew J Budoff; Daniel S Berman; Andrejs Erglis; Hyuk-Jae Chang; James K Min Journal: JACC Cardiovasc Imaging Date: 2015-01
Authors: B De Bruyne; F Hersbach; N H Pijls; J Bartunek; J W Bech; G R Heyndrickx; K L Gould; W Wijns Journal: Circulation Date: 2001-11-13 Impact factor: 29.690
Authors: James K Min; Jonathon Leipsic; Michael J Pencina; Daniel S Berman; Bon-Kwon Koo; Carlos van Mieghem; Andrejs Erglis; Fay Y Lin; Allison M Dunning; Patricia Apruzzese; Matthew J Budoff; Jason H Cole; Farouc A Jaffer; Martin B Leon; Jennifer Malpeso; G B John Mancini; Seung-Jung Park; Robert S Schwartz; Leslee J Shaw; Laura Mauri Journal: JAMA Date: 2012-09-26 Impact factor: 56.272
Authors: Teresa Infante; Ernesto Forte; Marco Aiello; Marco Salvatore; Carlo Cavaliere Journal: Front Endocrinol (Lausanne) Date: 2017-08-21 Impact factor: 5.555
Authors: Rebecca Jonas; James Earls; Hugo Marques; Hyuk-Jae Chang; Jung Hyun Choi; Joon-Hyung Doh; Ae-Young Her; Bon Kwon Koo; Chang-Wook Nam; Hyung-Bok Park; Sanghoon Shin; Jason Cole; Alessia Gimelli; Muhammad Akram Khan; Bin Lu; Yang Gao; Faisal Nabi; Ryo Nakazato; U Joseph Schoepf; Roel S Driessen; Michiel J Bom; Randall C Thompson; James J Jang; Michael Ridner; Chris Rowan; Erick Avelar; Philippe Généreux; Paul Knaapen; Guus A de Waard; Gianluca Pontone; Daniele Andreini; Mouaz H Al-Mallah; Robert Jennings; Tami R Crabtree; Todd C Villines; James K Min; Andrew D Choi Journal: Open Heart Date: 2021-11